Supplementary MaterialsSupporting Data Supplementary_Data. novel malignancy stemness-associated gene in ESCC and its association with survival was validated in a cohort of 121 patients with ESCC. These findings have profound potential implications for the use of cell cycle inhibitors in EAC and PARP inhibitors in ESCC, which may provide novel mechanistic insights into Masitinib pontent inhibitor… Continue reading Supplementary MaterialsSupporting Data Supplementary_Data. novel malignancy stemness-associated gene in ESCC and